Abstract
This study addresses a critical gap in the design of clinical trials that use grouped sequential designs for one-sample or paired ordinal categorical outcomes. Single-arm experiments, such as those using the modified Rankin Scale in stroke trials, underscore the necessity of our work. We present a novel method for applying the Wilcoxon signed-rank test to grouped sequences in these contexts. Our approach provides a practical and theoretical framework for assessing treatment effects, detailing variance formulas and demonstrating the asymptotic normality of the U-statistic. Through simulation studies and real data analysis, we validate the empirical Type I error rates and power. Additionally, we include a comprehensive flowchart to guide researchers in determining the required sample size to achieve specified power levels while controlling Type I error rates, thereby enhancing the design process of sequential trials.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
